Skip to main content

Table 1 In vitro potency and performance standards for susceptibility testing

From: Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use

Organism

MIC ranges (μg/ml)

 

Omadacycline

Tigecycline

Mycobacterium abscessus*

0.06–2

0.06–2

Mycobacterium chelonae*

0.015–0.25

0.03–0.125

Mycobacterium fortuitum*

0.03–1

0.03–1

Escherichia coli†

0.25–2

0.03–0.25

Staphylococcus aureus†

0.12–1

0.03–0.25

Enterococcus faecalis†

0.06–0.5

0.03–0.12

Bacteroides fragilis†

0.12–1

0.06–0.5

Clostridioides difficile†

0.06–0.25

0.03–0.12

  1. *Data from Shoen et al. [57]
  2. †Data from CLSI [97]
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us